CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ngeh J. Toyang

OPENALEX: A5004966468↗ORCID: 0000-0001-9683-6192↗

Affiliations

Organizations

490 BioTech (United States)authorship · US Bioscientifica (United Kingdom)authorship · GB

Public evidence

3 connected articles

From farm to bedside: Potential of medical cannabis in global health.2025 · Europe PMC Corrigendum: Flavonoid Derivative of <i>Cannabis</i> Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2020 · PubMed Central Open Access Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer.2019 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Ngeh J. Toyang - Medical Cannabis Research Engine